CLONICEL
USPTO Trademark Record · Serial No. 74437742
Trademark details
It was initially claimed by ADDRENEX PHARMACEUTICALS, INC. on 19930920.
That brand applies to the following goods and services:extended release capsules for oral administration containing the drug clonidine intended for the treatment of attention deficit hyperactivity disorders and other disorders characterized by excessive autonomic hyperactivity.
Currently that trademark is represented by trademark attorney(s): ARLENE D. HANKS.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the CLONICEL trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
